This thesis was an overview into the limitations of the older antiepileptic, emphasizing the need for newer treatment options in patients presenting with refractory epilepsy. It includes neuromodulatory therapies such as the vagus nerve stimulation, deep brain stimulation, the use of gene and molecular therapies and other newer pharmacological treatments such as cannabinoids, cenobamate, everolimus and stripentol.